Literature DB >> 4924318

Combined dihydralazine and propranolol in the treatment of hypertension.

M Katila, M H Frick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4924318

Source DB:  PubMed          Journal:  Int Z Klin Pharmakol Ther Toxikol


× No keyword cloud information.
  7 in total

1.  A controlled study on the antihypertensive effect of a new beta-adrenergic receptor blocking drug, metoprolol, in combination with chlorthalidone.

Authors:  A Jäättelä; K Pyörälä
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. The Italian Multicentre Study Group.

Authors:  S Caponnetto; E Valvo; P Mocarelli; D Alberti; S Savonitto
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

4.  Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.

Authors:  W Aenishänslin; J Pestalozzi-Kerpel; U C Dubach; P R Imhof; M Turri
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

5.  Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.

Authors:  M H Frick; P Pörsti
Journal:  Br Med J       Date:  1976-05-01

6.  Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.

Authors:  K O'Malley; M Velasco; J Wells; J McNay
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

7.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.